The Lack of Alterations in Metabolites in the Medial Prefrontal Cortex and Amygdala, but Their Associations with Autistic Traits, Empathy, and Personality Traits in Adults with Autism Spectrum Disorder: A Preliminary Study

J Autism Dev Disord. 2024 Jan;54(1):193-210. doi: 10.1007/s10803-022-05778-7. Epub 2022 Oct 17.

Abstract

Proton magnetic resonance spectroscopy (1H-MRS) has shown inconsistent alterations in brain metabolites of adults with autism spectrum disorder (ASD). We investigated brain metabolites in the medial prefrontal cortex and amygdala of 24 drug-naive adults with ASD and no intellectual disability and 24 non-ASD control subjects, using 3 T 1H-MRS. Adults with ASD showed no significant differences from control in glutamate, glutamate plus glutamine, N-acetylaspartate, glycerophosphorylcholine plus phosphorylcholine, creatine plus phosphocreatine, or myo-inositol in either region. However, ASD subjects did show significant correlations of localized brain metabolites with autistic traits, empathy deficits, and personality traits using the Autism-Spectrum Quotient, Questionnaire of Cognitive and Affective Empathy, Interpersonal Reactivity Index, and NEO Personality Inventory-Revised. These findings should be taken as preliminary or exploratory.

Keywords: ASD; Amygdala; Empathy; MRS; Medial prefrontal cortex; Personality traits.

MeSH terms

  • Adult
  • Amygdala / diagnostic imaging
  • Autism Spectrum Disorder* / metabolism
  • Autistic Disorder*
  • Empathy
  • Glutamic Acid / metabolism
  • Humans
  • Personality
  • Prefrontal Cortex / diagnostic imaging
  • Prefrontal Cortex / metabolism

Substances

  • Glutamic Acid